Proximal Anchoring of Nanodrugs through In Situ Generated Radical Hooks with Boosted Autophagy and Immunotherapy
Source abstract
Abstract
Efficient retention of drugs at tumor sites was always desirable to maximize therapeutic functions, yet the main concern is the dynamic blood clearance induced fast removal from localized lesion. Herein, a tumor microenvironment activated covalently conjugation (self- and proximal conjugation) of tyramine modified Pt nanoclusters (PCMT NPs) was constructed by in situ produced radical hooks, leading to efficient accumulation of PCMT NPs at tumor sites. Such accumulation further aggravated the oxidative stress and provoked autophagy of tumor cells via activating the caspase-3 pathway mediated massive apoptosis, thereby stimulating immunogenic cell death (ICD). As verified by in vivo results, the PCMT NPs effectively suppressed primary and distant tumor growth (with an inhibition rate of 99%) while eliciting immunotherapeutic responses. As such, a new paradigm for boosting drug retention was provided, which enabled specific tumor treatment with synergistic therapeutic outcomes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Supramolecular Self-Assembly in Materials · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing 100029, China
Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing 100029, China
Funding
Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Beijing Science and Technology Planning Project · National High Level Hospital Clinical Research Funding
References (28)
Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1126/sciadv.abq822510.1126/sciadv.abq8225 ↗
3. 10.1038/nrc.2017.9310.1038/nrc.2017.93 ↗
4. 10.1002/adma.20220958910.1002/adma.202209589 ↗
5. 10.1021/acs.chemrev.3c0006210.1021/acs.chemrev.3c00062 ↗
6. 10.1021/acsnano.9b0971310.1021/acsnano.9b09713 ↗
7. 10.1038/s41563-020-0755-z10.1038/s41563-020-0755-z ↗
8. 10.1002/anie.20210639210.1002/anie.202106392 ↗
9. 10.1021/acs.nanolett.6b0539610.1021/acs.nanolett.6b05396 ↗
10. 10.1038/s41467-022-33889-310.1038/s41467-022-33889-3 ↗
11. 10.1038/s41467-018-06271-510.1038/s41467-018-06271-5 ↗
12. 10.1002/anie.20211476610.1002/anie.202114766 ↗
13. 10.1002/anie.20210986310.1002/anie.202109863 ↗
14. 10.1016/j.nantod.2023.10211610.1016/j.nantod.2023.102116 ↗
15. 10.1002/anie.20231403910.1002/anie.202314039 ↗
16. 10.1002/smll.20210133210.1002/smll.202101332 ↗
17. 10.1002/anie.20201727310.1002/anie.202017273 ↗
18. 10.1002/advs.20180180610.1002/advs.201801806 ↗
19. 10.1002/anie.20211364910.1002/anie.202113649 ↗
20. 10.1002/anie.20181287810.1002/anie.201812878 ↗
21. 10.1021/jacs.0c1024510.1021/jacs.0c10245 ↗
22. 10.1038/s41563-019-0503-410.1038/s41563-019-0503-4 ↗
23. 10.1021/acs.analchem.8b0241910.1021/acs.analchem.8b02419 ↗
24. 10.1016/j.bios.2024.11626210.1016/j.bios.2024.116262 ↗
25. 10.1021/jacs.2c1115010.1021/jacs.2c11150 ↗
26. 10.1002/adma.20220663610.1002/adma.202206636 ↗
27. 10.1016/j.canlet.2024.21692710.1016/j.canlet.2024.216927 ↗
28. 10.1021/acsnano.1c1059010.1021/acsnano.1c10590 ↗